Pulse Biosciences (PLSE) Competitors $14.93 +0.06 (+0.40%) Closing price 04:00 PM EasternExtended Trading$14.92 -0.01 (-0.07%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PLSE vs. INSP, TMDX, NVST, PRCT, WRBY, LIVN, EYE, LMAT, NVCR, and SSIIShould you be buying Pulse Biosciences stock or one of its competitors? The main competitors of Pulse Biosciences include Inspire Medical Systems (INSP), TransMedics Group (TMDX), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), LeMaitre Vascular (LMAT), NovoCure (NVCR), and SS Innovations International (SSII). These companies are all part of the "medical equipment" industry. Pulse Biosciences vs. Its Competitors Inspire Medical Systems TransMedics Group Envista PROCEPT BioRobotics Warby Parker LivaNova National Vision LeMaitre Vascular NovoCure SS Innovations International Inspire Medical Systems (NYSE:INSP) and Pulse Biosciences (NASDAQ:PLSE) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings. Is INSP or PLSE more profitable? Inspire Medical Systems has a net margin of 7.92% compared to Pulse Biosciences' net margin of 0.00%. Inspire Medical Systems' return on equity of 10.00% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Inspire Medical Systems7.92% 10.00% 8.68% Pulse Biosciences N/A -68.44%-58.17% Which has more risk and volatility, INSP or PLSE? Inspire Medical Systems has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500. Do analysts rate INSP or PLSE? Inspire Medical Systems presently has a consensus target price of $208.55, suggesting a potential upside of 61.61%. Pulse Biosciences has a consensus target price of $22.00, suggesting a potential upside of 47.35%. Given Inspire Medical Systems' higher possible upside, equities research analysts plainly believe Inspire Medical Systems is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, INSP or PLSE? Inspire Medical Systems has higher revenue and earnings than Pulse Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspire Medical Systems$802.80M4.74$53.51M$2.1759.47Pulse Biosciences$700K1,434.77-$53.58MN/AN/A Does the media refer more to INSP or PLSE? In the previous week, Inspire Medical Systems had 8 more articles in the media than Pulse Biosciences. MarketBeat recorded 9 mentions for Inspire Medical Systems and 1 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 1.87 beat Inspire Medical Systems' score of 1.58 indicating that Pulse Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Inspire Medical Systems Very Positive Pulse Biosciences Very Positive Do insiders & institutionals have more ownership in INSP or PLSE? 94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 77.0% of Pulse Biosciences shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by insiders. Comparatively, 71.5% of Pulse Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryInspire Medical Systems beats Pulse Biosciences on 9 of the 14 factors compared between the two stocks. Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PLSE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLSE vs. The Competition Export to ExcelMetricPulse BiosciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.00B$6.85B$5.70B$9.51BDividend YieldN/A1.27%4.69%4.01%P/E RatioN/A19.2121.1920.14Price / Sales1,434.7763.54461.30104.37Price / CashN/A20.5536.2258.56Price / Book7.984.758.665.87Net Income-$53.58M$176.14M$3.25B$258.55M7 Day Performance-1.13%2.92%4.20%2.23%1 Month Performance-2.48%3.56%10.82%12.76%1 Year Performance-15.70%7.66%34.70%19.36% Pulse Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLSEPulse Biosciences3.9645 of 5 stars$14.93+0.4%$22.00+47.4%-18.9%$1.00B$700K0.00140Positive NewsINSPInspire Medical Systems4.8796 of 5 stars$125.13-1.3%$210.27+68.0%-8.0%$3.74B$802.80M57.661,246Positive NewsAnalyst ForecastTMDXTransMedics Group2.0984 of 5 stars$103.61-5.7%$129.88+25.3%-28.4%$3.72B$441.54M76.18210Positive NewsUpcoming EarningsNVSTEnvista3.3514 of 5 stars$19.47-0.2%$20.23+3.9%+26.8%$3.31B$2.51B-2.9812,300News CoverageUpcoming EarningsPRCTPROCEPT BioRobotics2.5011 of 5 stars$57.05-2.2%$84.13+47.5%-13.1%$3.23B$224.50M-33.56430News CoverageWRBYWarby Parker2.7407 of 5 stars$24.35+1.7%$22.88-6.0%+48.4%$2.50B$771.32M-202.903,780News CoverageInsider TradeLIVNLivaNova3.3409 of 5 stars$42.35+0.9%$59.29+40.0%-19.5%$2.29B$1.25B-10.352,900Upcoming EarningsEYENational Vision2.4992 of 5 stars$25.31+0.9%$22.10-12.7%+91.4%$1.98B$1.85B-76.6913,411Analyst ForecastLMATLeMaitre Vascular2.6656 of 5 stars$79.82+0.1%$97.83+22.6%-10.6%$1.80B$219.86M40.31490Positive NewsAnalyst ForecastNVCRNovoCure3.6093 of 5 stars$16.10+0.5%$32.43+101.4%-33.3%$1.79B$605.22M-10.661,488Trending NewsEarnings ReportAnalyst ForecastSSIISS Innovations InternationalN/A$8.40+5.9%N/AN/A$1.54B$20.65M0.004 Related Companies and Tools Related Companies INSP Competitors TMDX Competitors NVST Competitors PRCT Competitors WRBY Competitors LIVN Competitors EYE Competitors LMAT Competitors NVCR Competitors SSII Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLSE) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
